High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas
Background: Glioma is the most common primary tumor of the central nervous system and is associated with poor overall survival, creating an urgent need to identify survival-associated biomarkers. C1ORF112, an alpha-helical protein, is overexpressed in some cancers; however, its prognostic role has n...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/db9c373b212045329e0b6c792a818e93 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:db9c373b212045329e0b6c792a818e93 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:db9c373b212045329e0b6c792a818e932021-11-22T06:01:52ZHigh Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas1664-802110.3389/fgene.2021.710944https://doaj.org/article/db9c373b212045329e0b6c792a818e932021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.710944/fullhttps://doaj.org/toc/1664-8021Background: Glioma is the most common primary tumor of the central nervous system and is associated with poor overall survival, creating an urgent need to identify survival-associated biomarkers. C1ORF112, an alpha-helical protein, is overexpressed in some cancers; however, its prognostic role has not yet been explored in gliomas. Thus, in this study, we attempted to address this by determining the prognostic value and potential function of C1ORF112 in low-grade gliomas (LGGs).Methods: The expression of C1ORF112 in normal and tumor tissues was analyzed using data from The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), Oncomine, and Rembrandt databases. The genetic changes of C1ORF112 in LGG were analyzed using cBioPortal. Survival analysis was used to evaluate the relationship between C1ORF112 expression and survival in patients with LGG. Correlation between immune infiltration and C1ORF112 expression was determined using Timer software. Additionally, data from three online platforms were integrated to identify the co-expressed genes of C1ORF112. The potential biological functions of C1ORF112 were investigated by enrichment analysis.Results: C1ORF112 mRNA was highly expressed in LGGs (p < 0.01). Area under the ROC curve (AUC) showed that the expression of C1ORF112 in LGG was 0.673 (95% confidence interval [CI] = 0.618–0.728). Kaplan-Meier survival analysis showed that patients with high C1ORF112 expression had lower OS than patients with low C1ORF112 expression (p < 0.05). Multivariate analysis showed that high expression of C1ORF112 was an independent prognostic factor for the overall survival in patients from TCGA and CGGA databases. C1ORF112 expression was positively correlated with six immunoinfiltrating cells (all p < 0.001). The enrichment analysis suggested the enrichment of C1ORF112 and co-expressed genes in cell cycle and DNA replication.Conclusion: This study suggested that C1ORF112 may be a prognostic biomarker and a potential immunotherapeutic target for LGG.Zhe ZhangZilong TanQiaoli LvLichong WangKai YuHuan YangHuaizhen LiangTianzhu LuYulong JiJunjun ChenWei HeZhen ChenShuhui ChenXiaoli ShenFrontiers Media S.A.articleC1ORF112biomarkerimmunoinfiltrationlow-grade gliomaprognosisGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
C1ORF112 biomarker immunoinfiltration low-grade glioma prognosis Genetics QH426-470 |
| spellingShingle |
C1ORF112 biomarker immunoinfiltration low-grade glioma prognosis Genetics QH426-470 Zhe Zhang Zilong Tan Qiaoli Lv Lichong Wang Kai Yu Huan Yang Huaizhen Liang Tianzhu Lu Yulong Ji Junjun Chen Wei He Zhen Chen Shuhui Chen Xiaoli Shen High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas |
| description |
Background: Glioma is the most common primary tumor of the central nervous system and is associated with poor overall survival, creating an urgent need to identify survival-associated biomarkers. C1ORF112, an alpha-helical protein, is overexpressed in some cancers; however, its prognostic role has not yet been explored in gliomas. Thus, in this study, we attempted to address this by determining the prognostic value and potential function of C1ORF112 in low-grade gliomas (LGGs).Methods: The expression of C1ORF112 in normal and tumor tissues was analyzed using data from The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), Oncomine, and Rembrandt databases. The genetic changes of C1ORF112 in LGG were analyzed using cBioPortal. Survival analysis was used to evaluate the relationship between C1ORF112 expression and survival in patients with LGG. Correlation between immune infiltration and C1ORF112 expression was determined using Timer software. Additionally, data from three online platforms were integrated to identify the co-expressed genes of C1ORF112. The potential biological functions of C1ORF112 were investigated by enrichment analysis.Results: C1ORF112 mRNA was highly expressed in LGGs (p < 0.01). Area under the ROC curve (AUC) showed that the expression of C1ORF112 in LGG was 0.673 (95% confidence interval [CI] = 0.618–0.728). Kaplan-Meier survival analysis showed that patients with high C1ORF112 expression had lower OS than patients with low C1ORF112 expression (p < 0.05). Multivariate analysis showed that high expression of C1ORF112 was an independent prognostic factor for the overall survival in patients from TCGA and CGGA databases. C1ORF112 expression was positively correlated with six immunoinfiltrating cells (all p < 0.001). The enrichment analysis suggested the enrichment of C1ORF112 and co-expressed genes in cell cycle and DNA replication.Conclusion: This study suggested that C1ORF112 may be a prognostic biomarker and a potential immunotherapeutic target for LGG. |
| format |
article |
| author |
Zhe Zhang Zilong Tan Qiaoli Lv Lichong Wang Kai Yu Huan Yang Huaizhen Liang Tianzhu Lu Yulong Ji Junjun Chen Wei He Zhen Chen Shuhui Chen Xiaoli Shen |
| author_facet |
Zhe Zhang Zilong Tan Qiaoli Lv Lichong Wang Kai Yu Huan Yang Huaizhen Liang Tianzhu Lu Yulong Ji Junjun Chen Wei He Zhen Chen Shuhui Chen Xiaoli Shen |
| author_sort |
Zhe Zhang |
| title |
High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas |
| title_short |
High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas |
| title_full |
High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas |
| title_fullStr |
High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas |
| title_full_unstemmed |
High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas |
| title_sort |
high expression of c1orf112 predicts a poor outcome: a potential target for the treatment of low-grade gliomas |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/db9c373b212045329e0b6c792a818e93 |
| work_keys_str_mv |
AT zhezhang highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT zilongtan highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT qiaolilv highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT lichongwang highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT kaiyu highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT huanyang highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT huaizhenliang highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT tianzhulu highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT yulongji highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT junjunchen highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT weihe highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT zhenchen highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT shuhuichen highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas AT xiaolishen highexpressionofc1orf112predictsapooroutcomeapotentialtargetforthetreatmentoflowgradegliomas |
| _version_ |
1718418132202160128 |